Literature DB >> 26537120

Comprehensive capture of cutaneous melanoma by the Ontario Cancer Registry: validation study using community pathology reports.

Jennifer M Tran1, Rodrigo Schwartz2,3, Kinwah Fung4,5, Paula Rochon4,5, An-Wen Chan6,7,8.   

Abstract

Melanoma is often managed outside hospital settings, creating the potential for underreporting to cancer registries. To our knowledge, completeness of melanoma capture in cancer registries has not been assessed using external data sources since the 1980s. We evaluated the melanoma capture rate from 1993 to 2009 in a provincial cancer registry. We identified all melanoma diagnoses in pathology reports from a major community laboratory in Ontario, Canada. Pathologically confirmed diagnoses were linked to Ontario Cancer Registry (OCR) records using health insurance numbers. We calculated capture rates as the proportion of patients with melanoma confirmed by a pathology report, with a corresponding melanoma diagnosis in OCR. OCR captured 3,798 of 4,275 (88.8, 95 % confidence interval: 87.9, 89.8 %) invasive melanoma diagnoses over the 17-year period. Annual capture rates of 94 % or higher were found for over half the study period. Among all 29,133 melanoma diagnoses in OCR, 27.6 % were registered based on a pathology report alone, compared with 3.4 % for non-cutaneous malignancies. This suggests that comprehensive capture of melanoma cases by a provincial cancer registry is achievable using source data from community laboratories. There is a need for ongoing validation to ensure data remain accurate and complete to reliably inform clinical care, research, and policy.

Entities:  

Keywords:  Cancer; Cancer registries; Cancer reporting; Melanoma; Validation

Mesh:

Year:  2015        PMID: 26537120     DOI: 10.1007/s10552-015-0690-5

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  9 in total

1.  A population-based validation study of the 8th edition UICC/AJCC TNM staging system for cutaneous melanoma.

Authors:  Matthew C Hynes; Paul Nguyen; Patti A Groome; Yuka Asai; Meaghan E Mavor; Tara D Baetz; Timothy P Hanna
Journal:  BMC Cancer       Date:  2022-07-01       Impact factor: 4.638

2.  Disparities in diagnosis of advanced melanoma: a population-based cohort study.

Authors:  Meaghan E Mavor; Harriet Richardson; Qun Miao; Yuka Asai; Timothy P Hanna
Journal:  CMAJ Open       Date:  2018-10-31

3.  Association of Innovations in Radiotherapy and Systemic Treatments With Clinical Outcomes in Patients With Melanoma Brain Metastasis From 2007 to 2016.

Authors:  Harry C Brastianos; Paul Nguyen; Arjun Sahgal; Elizabeth A Eisenhauer; Tara Baetz; Timothy P Hanna
Journal:  JAMA Netw Open       Date:  2020-07-01

4.  A population-based study of the treatment effect of first-line ipilimumab for metastatic or unresectable melanoma.

Authors:  Erik Drysdale; Yingwei Peng; Paul Nguyen; Tara Baetz; Timothy P Hanna
Journal:  Melanoma Res       Date:  2019-12       Impact factor: 3.599

5.  Impact of the COVID-19 pandemic on skin cancer diagnosis: A population-based study.

Authors:  Yuka Asai; Paul Nguyen; Timothy P Hanna
Journal:  PLoS One       Date:  2021-03-31       Impact factor: 3.240

6.  Association between antihypertensive medications and risk of skin cancer in people older than 65 years: a population-based study.

Authors:  Aaron M Drucker; Loes Hollestein; Yingbo Na; Martin A Weinstock; Wen-Qing Li; Husam Abdel-Qadir; An-Wen Chan
Journal:  CMAJ       Date:  2021-04-12       Impact factor: 8.262

7.  A population-based study of administrative data linkage to measure melanoma surgical and pathology quality.

Authors:  Douglas R McKay; Paul Nguyen; Ami Wang; Timothy P Hanna
Journal:  PLoS One       Date:  2022-02-18       Impact factor: 3.240

8.  Incidence and mortality rates of keratinocyte carcinoma from 1998-2017: a population-based study of sex differences in Ontario, Canada.

Authors:  Evan Tang; Kinwah Fung; An-Wen Chan
Journal:  CMAJ       Date:  2021-10-04       Impact factor: 8.262

9.  Patient, physician and geographic predictors of cardiac stress testing strategy in Ontario, Canada: a population-based study.

Authors:  Idan Roifman; Lu Han; Jiming Fang; Anna Chu; Peter Austin; Dennis T Ko; Pamela Douglas; Harindra Wijeysundera
Journal:  BMJ Open       Date:  2022-03-10       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.